Is vegf a key target of cotinine and other potential therapies against alzheimer disease?

Current Alzheimer Research

dc.creatorEcheverria, Valentina
dc.creatorBarreto, George E
dc.creatorAvila-Rodriguez, Marco
dc.creatorTarasov, Vadim V
dc.creatorAliev, Gjumrakch
dc.date2018-12-07T13:32:46Z
dc.date2022-07-07T21:32:27Z
dc.date2015
dc.date2018-12-07T13:32:46Z
dc.date2022-07-07T21:32:27Z
dc.date2017
dc.date.accessioned2023-08-23T00:13:49Z
dc.date.available2023-08-23T00:13:49Z
dc.identifier1150194
dc.identifier1150194
dc.identifierhttps://hdl.handle.net/10533/232034
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8354307
dc.descriptionBackground: The vascular endothelial growth factor (VEGF) is a neuroprotective cytokine that promotes neurogenesis and angiogenesis in the brain. In animal models, it has been shown that environmental enrichment and exercise, two non-pharmacological inte
dc.descriptionRegular
dc.descriptionFONDECYT
dc.descriptionFONDECYT
dc.languageeng
dc.relationhandle/10533/111557
dc.relationhandle/10533/111541
dc.relationhandle/10533/108045
dc.relationhttp://www.eurekaselect.com/151181/article
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleIs vegf a key target of cotinine and other potential therapies against alzheimer disease?
dc.titleCurrent Alzheimer Research
dc.typeArticulo
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución